Sport

Stock Roaring Upward Mid-Session: Seattle Genetics, Inc. (NASDAQ:SGEN)

As of writing, Seattle Genetics, Inc.'s RSI stands at 78.63. (NASDAQ:SGEN). Ubs Asset Mgmt Americas Inc reported 0% stake. The brokerage now has a hold rating on the biotechnology company's stock. The firm has "Hold" rating by Cowen & Co given on Thursday, July 27. About 5,116 shares traded. SunTrust Banks, Inc. reaffirmed a hold rating and set a $45.00 target price on shares of Seattle Genetics in a report on Wednesday, October 4th. Verizon Communications Inc. had 51 analyst reports since July 22, 2015 according to SRatingsIntel. Piper Jaffray has "Hold" rating and $4800 target. Cognios Capital Llc sold 4,936 shares as the company's stock declined 2.84% while stock markets rallied. (NASDAQ:SGEN) recently. President and CEO Clay B. Siegall let go of 18,832 shares at an average price of $53.79 on Monday the 11th. Seattle Genetics, Inc. (NASDAQ:SGEN) has risen 75.68% since October 11, 2016 and is uptrending. Current price levels see the company 11.61% off the 20-day simple moving average. The stock's market cap is $8.30 billion. Cann reaffirmed a "hold" rating on shares of Seattle Genetics in a report on Thursday, April 27th. The biotechnology company reported ($0.42) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.41) by $0.01. The business had revenue of $108.20 million for the quarter, compared to analyst estimates of $105.92 million. Seattle Genetics had a negative return on equity of 32.87% and a negative net margin of 47.38%. During the same quarter in the previous year, the firm earned ($0.15) earnings per share.

A number of key analysts, polled by FactSet, shared their views about the current stock momentum.

Molecular Templates, Inc. (:MTEM)'s stock has performed at 102.84%. "(SGEN) Given a $46.00 Price Target at Cantor Fitzgerald" was originally posted by TrueBlueTribune and is owned by of TrueBlueTribune. If you are viewing this article on another website, it was illegally copied and reposted in violation of USA & worldwide copyright and trademark laws. It is quantified by short-term traders as the average difference between a stock's daily high and daily low, then divided by the stock price. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 10,000 shares were sold by HIMES VAUGHN B, worth $625,922. The shares were sold at an average price of $54.54, for a total value of $545,400.00. The disclosure for this sale can be found here. Inc. now owns 245,073 shares of the biotechnology company's stock worth $13,236,000 after buying an additional 152,504 shares in the last quarter.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in SGEN.

Shares of Seattle Genetics, Inc. are presently 34.99% off the 52 week low. Jane Street Group LLC acquired a new position in shares of Seattle Genetics during the third quarter worth $485,000. The institutional investor held 20,000 shares of the major banks company at the end of 2017Q2, valued at $1.02M, up from 7,000 at the end of the previous reported quarter. First Manhattan Co. lifted its stake in shares of Seattle Genetics by 31.3% in the 2nd quarter. Insiders sold a total of 38,930 shares of company stock worth $2,522,849 over the last 90 days. Piper Jaffray maintained Seattle Genetics, Inc. Following the transaction, the insider now directly owns 646,858 shares in the company, valued at approximately $40,745,585.42. Knowing how to interpret the information is another skill investors may need to master before becoming fully immersed in the stock market. More interesting news about Seattle Genetics, Inc. The Firm is engaged in the development and sale of pharmaceutical products on its own behalf or in collaboration with others. (NASDAQ:SGEN) were released by: Seekingalpha.com and their article: "Seattle Genetics: Good Time To Buy Based On Adcetris Label Expansion" published on September 15, 2017 as well as Globenewswire.com's news article titled: "Genmab and Seattle Genetics to Initiate New Study of Novel Antibody-Drug ..." with publication date: October 10, 2017.



Like this

Latest


12 October 2017
Company stock datas that defines today's share market: Cardinal Health, Inc. (CAH)
The stock of Cardinal Health Inc (NYSE:CAH) has "Outperform" rating given on Thursday, February 11 by RBC Capital Markets. It has underperformed by 21.65% the S&P500. ( CAH ) by 92.81% based on its latest 2017Q2 regulatory filing with the SEC.

12 October 2017
Horizon Pharma, Inc. (NASDAQ:HZNP) Valuation According To Analysts
Therefore 77% are positive. 07/14/2016 - Horizon Pharma , Inc. had its "buy" rating reiterated by analysts at Brean Capital. The company has experienced volume of 2,325,091 shares while on average the company has a capacity of trading 3.62M share.

12 October 2017
Israel OKs plans to build in settlements
It is holy to both religions, with Old Testament figures including Abraham believed to be buried there. Most nations consider the settlements illegal.

12 October 2017
Antero Resources Corporation (AR) Now Covered by Jefferies Group LLC
Finally, TD Asset Management Inc. raised its stake in shares of Antero Resources Corporation by 4.4% during the 1st quarter. Bank of New York Mellon Corp grew its stake in shares of Antero Resources Corporation by 6.4% in the 1st quarter.

12 October 2017
'Incorporate mental health into human resource management'
She will be sharing her story of addiction and mental health to students at Menihek High School April 25 as part of is National Mental Health Awareness Week.

12 October 2017
Gun control group sues 'bump stock' makers over Las Vegas shooting massacre
The Brady Center to Prevent Gun Violence filed the lawsuit on behalf of victims of the October 1 shooting in Las Vegas. Anna Perez, a local gun control advocate, said she is a gun owner but believes bump stocks need to be banned.

12 October 2017
Rothstein | Trent Johnson to join Louisville coaching staff
Padgett took over the role after longtime head coach Rick Pitino was "effectively" fired from the program in late September. University of Louisville interim men's basketball coach David Padgett has named a new assistant to his depleted staff.

12 October 2017
Robert W. Baird Believes Fidelity National Info (NYSE: FIS) Won't Stop Here
After $0.28 actual EPS reported by General Electric Company for the previous quarter, Wall Street now forecasts 78.57% EPS growth. Its down 0.25, from 1.19 in 2017Q1. 281.10 million shares or 0.32% more from 280.19 million shares in 2017Q1 were reported.

12 October 2017
BB&T Securities LLC Decreases Holdings in Medtronic PLC (MDT)
Sales growth quarter over quarter is 3.10%, with EPS growth quarter over quarter coming to a value of 11.90%. The management of the company has seen, a return of investment of 5.70% and return on assets of 4.20%.

12 October 2017
Digital Realty Trust Inc (NYSE:DLR) Institutional Investor Sentiment Analysis
Among 39 analysts covering Whiting Petroleum Corporation ( NYSE:WLL ), 10 have Buy rating, 7 Sell and 22 Hold. Barclays Capital maintained it with "Equal-Weight" rating and $10 target in Thursday, February 18 report.



Recommended